---
title: "Semax"
slug: "semax"
type: "compound"
category: "Cognitive"
url: "https://peptidesciencethailand.com/compounds/semax"
description: "Semax boosts BDNF and dopamine for sharper focus and memory. Russian-approved nootropic peptide: mechanism, dosing, and clinical evidence reviewed."
---
# Semax

*Neurogenic Peptide, BDNF Upregulation for Cognitive Enhancement*

**Category:** Cognitive  
**Format:** Nasal Spray Prep  
**Amount:** 30mg  
**Purity:** >99.8% (HPLC)

## Overview

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide analogue derived from the adrenocorticotropic hormone (ACTH) fragment 4-10. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in the 1980s, Semax has been approved as a prescription medication in Russia and several CIS countries since 2001, primarily for cognitive enhancement, neuroprotection, and stroke recovery. Its development represents one of the most clinically validated nootropic peptides in existence, with over three decades of research supporting its neurological applications.

Semax's mechanism of action centers on modulation of neurotrophic factor expression, particularly Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF). BDNF is a critical protein that supports neuronal survival, promotes synaptic plasticity (the basis of learning and memory), and stimulates neurogenesis, the growth of new neurons, particularly in the hippocampus. Research published in Doklady Biological Sciences demonstrated that Semax significantly upregulates BDNF mRNA expression in the hippocampus and cortex within hours of administration, with effects persisting for up to 24 hours after a single dose.

Beyond neurotrophic modulation, Semax influences multiple neurotransmitter systems simultaneously. It modulates dopaminergic transmission, increasing dopamine and its metabolite DOPAC levels in brain regions associated with executive function and motivation. Simultaneously, it affects serotonergic pathways, influencing mood regulation and emotional processing. Research has documented Semax's inhibition of enkephalinases, enzymes that degrade endogenous opioid peptides, which may contribute to its anxiolytic and mood-stabilizing properties without producing dependence or tolerance.

Semax also exerts significant effects on gene expression. Transcriptomic studies have revealed that it modulates the expression of over 1,000 genes in the brain, with particular influence on pathways related to immune response, vascular function, and neuronal survival. This broad transcriptomic footprint explains its diverse pharmacological effects and distinguishes it from synthetic nootropics that typically act on single receptor systems.

In clinical settings, Semax has been administered intranasally at doses of 200-600mcg per day. Its clinical applications in Russia include treatment of cognitive disorders, optic nerve diseases, immune system modulation, and as an adjunct therapy in ischemic stroke recovery. A clinical study involving stroke patients demonstrated improved neurological outcomes when Semax was administered within the first 6 hours of ischemic events, attributed to its neuroprotective and neurotrophic properties.

The peptide's favorable safety profile has been documented across decades of clinical use. Unlike stimulant-based cognitive enhancers, Semax does not produce cardiovascular stimulation, appetite suppression, or sleep disruption. Its effects on cognition are described as enhancing clarity, focus, and information processing speed without the jitteriness or crash associated with traditional stimulants.

specialist consultation is important for Semax protocols because its effects on neurotransmitter systems mean it can interact with psychiatric medications, particularly SSRIs, MAOIs, and dopaminergic agents. Individuals with psychiatric conditions require careful assessment to ensure Semax complements rather than conflicts with existing treatment regimens.

## Mechanism of Action

### Step 1: BDNF & NGF Upregulation

Semax rapidly increases expression of Brain-Derived Neurotrophic Factor and Nerve Growth Factor in the hippocampus and cortex, enhancing the molecular foundation for synaptic plasticity, learning, and neuronal survival.

### Step 2: Dopaminergic Modulation

The peptide modulates dopamine and DOPAC levels in prefrontal and limbic regions, enhancing executive function, motivation, and attentional control without the tolerance-building seen with stimulant compounds.

### Step 3: Serotonergic Pathway Influence

Semax modulates serotonergic transmission, contributing to mood stabilization and emotional regulation. This dual monoamine modulation underlies its cognitive-emotional balancing effects.

### Step 4: Enkephalinase Inhibition

By inhibiting enzymes that degrade endogenous opioid peptides, Semax preserves natural enkephalin levels, contributing to anxiolytic and mood-stabilizing effects without producing dependence.

### Step 5: Broad Transcriptomic Response

Semax modulates expression of 1,000+ genes involved in immune response, vascular function, and neuronal survival, creating a comprehensive neuroprotective and neuroenhancing environment.

## Researched Benefits

### Cognitive Enhancement

Semax enhances focus, mental clarity, and information processing speed through BDNF-mediated synaptic plasticity and dopaminergic modulation. Unlike stimulant-based nootropics, these cognitive improvements occur without cardiovascular stimulation, appetite suppression, or energy crashes.

### Neuroprotection

Through upregulation of neurotrophic factors and modulation of over 1,000 neuroprotective genes, Semax supports neuronal survival and resilience. Clinical research in stroke patients has demonstrated improved neurological outcomes, attributed to its ability to protect neurons under ischemic stress.

### Memory & Learning Support

BDNF upregulation in the hippocampus, the brain's primary memory center, enhances synaptic plasticity and neurogenesis. These molecular changes support improved encoding, consolidation, and retrieval of information, the fundamental processes underlying learning and memory formation.

### Mood Stabilization

Semax's combined modulation of serotonergic pathways and enkephalinase inhibition produces anxiolytic and mood-stabilizing effects without sedation or emotional blunting. This makes it suitable for cognitive enhancement in individuals who also experience stress-related cognitive impairment.

## Dosage & Administration

| Parameter | Detail |
| --- | --- |
| Protocol | 200-600mcg per day, administered intranasally in 1-3 divided doses |
| Route | Intranasal administration |
| Duration | 10-20 day cycles |
| Cycle Notes | Standard protocols run 10-20 days followed by an equal rest period. Some protocols use 14 days on / 14 days off cycling. Effects are often noted within the first 2-3 days of administration. |
| Reconstitution | Semax is typically supplied in a nasal spray preparation. If supplied as lyophilized powder, reconstitute with the provided nasal spray diluent per instructions. Store at 2-8°C once reconstituted. |

> **Specialist note:** A specialist would determine the appropriate dose based on cognitive goals, existing medication regimen, and neurological status. Individuals taking psychiatric medications, particularly SSRIs, MAOIs, or dopaminergic agents, require careful dose calibration to avoid neurotransmitter interactions.

## Compound Reference Data

| Property | Value |
| --- | --- |
| Format | Nasal Spray Preparation |
| Amount | 30mg total |
| Purity | >99.8% |
| Purity Method | HPLC (High-Performance Liquid Chromatography) |
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro |
| Molecular Weight | 813.93 g/mol |
| Storage | Store at 2-8°C. Protect from light. Use within 30 days of opening. |
| Appearance | Clear to slightly yellow solution |

## Medical Guidance

Semax modulates dopaminergic and serotonergic neurotransmitter systems, making specialist consultation essential for anyone taking psychiatric medications including SSRIs, SNRIs, MAOIs, or antipsychotics. Individuals with a history of seizure disorders, bipolar disorder, or psychotic episodes require careful neurological assessment before initiating Semax protocols, as neurotransmitter modulation may influence these conditions.

## Frequently Asked Questions

### What is Semax and how was it developed?

Semax is a synthetic heptapeptide derived from the ACTH(4-10) fragment, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in the 1980s. It has been approved as a prescription medication in Russia since 2001 for cognitive enhancement and neuroprotection. Over three decades of research support its effects on BDNF upregulation, neurotransmitter modulation, and cognitive performance enhancement.

### What medical guidance applies to Semax?

Semax is a compound studied in clinical research that should only be used under qualified medical supervision. A specialist consultation helps ensure the dose is appropriate for neurological profile, that potential interactions with existing medications (particularly psychiatric drugs) are assessed, and that cognitive goals are addressed safely. This is essential for both safety and informed decision-making.

### How quickly does Semax take effect?

Many users and clinical observations report noticeable cognitive effects within the first 2-3 days of intranasal administration. BDNF upregulation occurs within hours of the first dose, though the full neuroplasticity benefits develop over the course of a 10-20 day cycle. Effects are typically described as enhanced mental clarity, improved focus duration, and faster information processing without stimulant-like side effects.

### Is Semax different from stimulant-based nootropics?

Yes, fundamentally. Semax enhances cognition through neurotrophic factor upregulation (BDNF, NGF) and neurotransmitter modulation rather than direct receptor stimulation. It does not produce cardiovascular stimulation, appetite suppression, sleep disruption, or the tolerance and withdrawal patterns associated with stimulant nootropics. Its effects are described as a natural enhancement of cognitive clarity rather than artificial stimulation.

### Can Semax be combined with Selank?

Research protocols sometimes investigate Semax and Selank in combination, as they have complementary cognitive-emotional profiles. Semax provides stimulating nootropic effects through dopaminergic modulation and BDNF upregulation, while Selank offers anxiolytic calming effects through GABAergic modulation. A your specialist can determine whether this combination is appropriate based on cognitive goals and neurological profile.

## Related Compounds

- /compounds/selank
- /compounds/bpc-157
- /compounds/epithalon

## Comparisons

- /compare/semax-vs-selank